After a previously reported positive phase 2 trial in systemic lupus erythematosus (SLE), the TYK2 inhibitor deucravacitinib ...

Anifrolumab can substantially lower the risk for long-term organ damage progression in patients with moderate to severe ...

Pericarditis recurrence in lupus is more likely — and has a dose-dependent relationship — with oral prednisone treatment, ...

Systemic lupus erythematosus (SLE) is the most common type of lupus. According to 2019 criteria from the ACR and EULAR, you must have antinuclear antibodies to receive an SLE diagnosis.

billed as the first oral treatment for active nephritis in patients with the autoimmune disease systemic lupus erythematosus. Kidney inflammation caused by SLE is referred to as lupus nephritis ...

Lupus-related antibody shows promise in enhancing cancer treatment efficacy. ScienceDaily . Retrieved April 2, 2025 from www.sciencedaily.com / releases / 2025 / 03 / 250325141527.htm ...

Novartis' soon-to-be-divested Sandoz unit has positive clinical trial data in hand for a biosimilar of Amgen's blockbuster osteoporosis therapy Prolia (denosumab), clearing the way for regulatory ...

an oral Janus kinase 1 selective inhibitor, in adults 18 years and older with moderate to severe HS. To be enrolled in the studies, patients had to have a total abscess and inflammatory nodule (AN) ...

Diagnosis of systemic lupus erythematosus meeting the 2019 European League Against Rheumatism/American College of Rheumatology (EULAR/ACR) SLE classification criteria at least 6 months prior to ...

A salt water rinse is sometimes recommended for treating oral candidiasis or oral thrush, though it is unclear whether this is effective against Candida albicans. Older research has found that C.

Livedo reticularis is a mottled discoloration of the skin. The discoloration may appear blotchy with a net-like pattern and range from reddish-blue to purple. 1,2 Although the terms used in the ...